{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:10:00Z","timestamp":1788869400517,"version":"build-2803163510"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006668","name":"Fondo para la Investigaci\u00c3\u00b3n Cient\u00c3\u00adfica y Tecnol\u00c3\u00b3gica","doi-asserted-by":"publisher","award":["PICT2007-00539"],"award-info":[{"award-number":["PICT2007-00539"]}],"id":[{"id":"10.13039\/501100006668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00c3\u00b3n Cient\u00c3\u00adfica y Tecnol\u00c3\u00b3gica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00c3\u00adficas y T\u00c3\u00a9cnicas","doi-asserted-by":"publisher","award":["PIP 112 200801 02920\/2009\u20132012"],"award-info":[{"award-number":["PIP 112 200801 02920\/2009\u20132012"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.intimp.2014.06.021","type":"journal-article","created":{"date-parts":[[2014,6,25]],"date-time":"2014-06-25T10:15:11Z","timestamp":1403691311000},"page":"167-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Suicide plus immune gene therapy prevents post-surgical local relapse and increases overall survival in an aggressive mouse melanoma setting"],"prefix":"10.1016","volume":"22","author":[{"given":"Marcela S.","family":"Villaverde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristell","family":"Combe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana G.","family":"Duchene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming X.","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo C.","family":"Glikin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana M.E.","family":"Finocchiaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2014.06.021_bb0005","first-page":"488","article-title":"Treatment of metastatic melanoma: an overview","volume":"23","author":"Bhatia","year":"2009","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.intimp.2014.06.021_bb0010","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"Chapman","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.intimp.2014.06.021_bb0015","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1056\/NEJMoa1210093","article-title":"Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations","volume":"367","author":"Flaherty","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.intimp.2014.06.021_bb0020","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1056\/NEJMoa1104621","article-title":"Ipilimumab plus dacarbazine for previously untreated metastatic melanoma","volume":"364","author":"Robert","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.intimp.2014.06.021_bb0025","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1354\/vp.37-6-597","article-title":"Retrospective study of 338 canine oral melanomas with clinical, histologic, and immunohistochemical review of 129 cases","volume":"37","author":"Ramos-Vara","year":"2000","journal-title":"Vet Pathol"},{"key":"10.1016\/j.intimp.2014.06.021_bb0030","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1354\/vp.39-6-651","article-title":"A comparative review of melanocytic neoplasms","volume":"39","author":"Smith","year":"2002","journal-title":"Vet Pathol"},{"key":"10.1016\/j.intimp.2014.06.021_bb0035","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/sj.gt.3303072","article-title":"Cytokine-enhanced vaccine and suicide gene therapy as surgery adjuvant treatments for spontaneous canine melanoma","volume":"15","author":"Finocchiaro","year":"2008","journal-title":"Gene Ther"},{"key":"10.1016\/j.intimp.2014.06.021_bb0040","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/cgt.2012.72","article-title":"Cytokine-enhanced vaccine and suicide gene therapy as surgery adjuvant treatments for spontaneous canine melanoma: 9years of follow-up","volume":"19","author":"Finocchiaro","year":"2012","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.intimp.2014.06.021_bb0045","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/sj.cgt.7701096","article-title":"Suicide gene and cytokines combined non viral gene therapy for canine spontaneous melanoma","volume":"15","author":"Finocchiaro","year":"2008","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.intimp.2014.06.021_bb0050","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/gt.2009.107","article-title":"Suicide gene therapy on spontaneous canine melanoma: correlations between in vivo tumors and the corresponding derived in vitro multicellular spheroids","volume":"17","author":"Gil Cardeza","year":"2010","journal-title":"Gene Ther"},{"key":"10.1016\/j.intimp.2014.06.021_bb0055","doi-asserted-by":"crossref","first-page":"c869","DOI":"10.1136\/bmj.c869","article-title":"CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Moher","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.intimp.2014.06.021_bb0060","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1006\/mthe.2001.0433","article-title":"Elimination of the truncated message from the herpes simplex virus thymidine kinase suicide gene","volume":"4","author":"Chalmers","year":"2001","journal-title":"Mol Ther"},{"key":"10.1016\/j.intimp.2014.06.021_bb0065","first-page":"3022","article-title":"Herpes simplex virus-1 thymidine kinase mutants created by semi-random sequence mutagenesis improve prodrug-mediated tumor cell killing","volume":"61","author":"Black","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.intimp.2014.06.021_bb0070","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s00109-011-0777-8","article-title":"Cancer suicide gene therapy with TK.007: superior killing efficiency and bystander effect","volume":"89","author":"Preuss","year":"2011","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.intimp.2014.06.021_bb0075","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1158\/1535-7163.MCT-10-0717","article-title":"Effective melanoma immunotherapy with interleukin-2 delivered by a novel polymeric nanoparticle","volume":"10","author":"Yao","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.intimp.2014.06.021_bb0080","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/sj.cgt.7700589","article-title":"Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing","volume":"10","author":"Wiewrodt","year":"2003","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.intimp.2014.06.021_bb0085","doi-asserted-by":"crossref","first-page":"e26142","DOI":"10.1371\/journal.pone.0026142","article-title":"Oncolytic adenoviruses armed with thymidine kinase can be traced by PET imaging and show potent antitumoural effects by ganciclovir dosing","volume":"6","author":"Abate-Daga","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2014.06.021_bb0090","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/cgt.2012.95","article-title":"Recent developments in oncolytic adenovirus-based immunotherapeutic agents for use against metastatic cancers","volume":"20","author":"Choi","year":"2013","journal-title":"Cancer Gene Ther"},{"issue":"110","key":"10.1016\/j.intimp.2014.06.021_bb0095","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1038\/bjc.2014.162","article-title":"Tumour-infiltrating CD4(+) and CD8(+) lymphocytes as predictors of clinical outcome in glioma","volume":"13","author":"Han","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.intimp.2014.06.021_bb0100","doi-asserted-by":"crossref","first-page":"8162","DOI":"10.1016\/j.vaccine.2010.09.095","article-title":"Vaccination with dendritic cells charged with apoptotic\/necrotic B16 melanoma induces the formation of subcutaneous lymphoid tissue","volume":"28","author":"Mac Keon","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2014.06.021_bb0105","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1200\/JCO.2007.15.0284","article-title":"Long term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures","volume":"26","author":"Dieu-Nosjean","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.intimp.2014.06.021_bb0110","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/hpb.12028","article-title":"Extended pathology reporting of resection specimens of colorectal liver metastases: the significance of a tumour pseudocapsule","volume":"15","author":"Wiggans","year":"2013","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.intimp.2014.06.021_bb0115","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/1097-0142(20000715)89:2<267::AID-CNCR10>3.0.CO;2-1","article-title":"Fibrous pseudocapsule of metastatic liver tumors from colorectal carcinoma. Clinicopathologic study of 152 first resection cases","volume":"89","author":"Okano","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.intimp.2014.06.021_bb0120","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00003086-199403000-00031","article-title":"Inflammatory cells in the pseudocapsule of osteosarcoma. A clinicopathologic analysis","volume":"300","author":"Miura","year":"1994","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.intimp.2014.06.021_bb0125","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s11999-013-3022-7","article-title":"Chemotherapy influences the pseudocapsule composition in soft tissue sarcomas","volume":"472","author":"O'Donnell","year":"2014","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.intimp.2014.06.021_bb0130","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00003086-198909000-00040","article-title":"Characterization of the pseudocapsule of soft-tissue sarcomas. An experimental study in rats","volume":"246","author":"Gitelis","year":"1989","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.intimp.2014.06.021_bb0135","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ymthe.2004.09.008","article-title":"Induction of IFN-regulated factors and antitumoral surveillance by transfected placebo plasmid DNA","volume":"11","author":"Li","year":"2005","journal-title":"Mol Ther"},{"key":"10.1016\/j.intimp.2014.06.021_bb0140","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nm0897-849","article-title":"Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants","volume":"3","author":"Roman","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.intimp.2014.06.021_bb0145","doi-asserted-by":"crossref","first-page":"17412","DOI":"10.1073\/pnas.0508698102","article-title":"Visualization of a primary anti-tumor immune response by positron emission tomography","volume":"102","author":"Shu","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.intimp.2014.06.021_bb0150","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.gde.2009.10.008","article-title":"Visualizing cancer and immune cell function with metabolic positron emission tomography","volume":"20","author":"Laing","year":"2010","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.intimp.2014.06.021_bb0155","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni1102-991","article-title":"Cancer immunoediting: from immunosurveillance to tumor escape","volume":"3","author":"Dunn","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.intimp.2014.06.021_bb0160","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1126\/science.1203486","article-title":"Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion","volume":"331","author":"Schreiber","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.intimp.2014.06.021_bb0165","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1158\/0008-5472.CAN-05-1299","article-title":"Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host","volume":"66","author":"Huang","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.intimp.2014.06.021_bb0170","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3389\/fimmu.2012.00165","article-title":"Functional crosstalk between dendritic cells and Foxp3(+) regulatory T cells in the maintenance of immune tolerance","volume":"3","author":"Kornete","year":"2012","journal-title":"Front Immunol"},{"key":"10.1016\/j.intimp.2014.06.021_bb0175","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.4049\/jimmunol.180.5.2967","article-title":"Expression of ICOS on human melanoma-infiltrating CD4+CD25highFoxp3+ T regulatory cells: implications and impact on tumor-mediated immune suppression","volume":"80","author":"Strauss","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2014.06.021_bb0180","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/intimm\/dxm014","article-title":"Activation-induced FoxP3 in human T effector cells does not suppress proliferation or cytokine production","volume":"19","author":"Allan","year":"2007","journal-title":"Int Immunol"},{"key":"10.1016\/j.intimp.2014.06.021_bb0185","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/1479-5876-9-204","article-title":"A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma","volume":"9","author":"Hamid","year":"2011","journal-title":"J Transl Med"},{"key":"10.1016\/j.intimp.2014.06.021_bb0190","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/mt.2010.268","article-title":"DAI (DLM-1\/ZBP1) as a genetic adjuvant for DNA vaccines that promotes effective antitumor CTL immunity","volume":"19","author":"Lladser","year":"2011","journal-title":"Mol Ther"},{"key":"10.1016\/j.intimp.2014.06.021_bb0195","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1476-5810.2004.0053b.x","article-title":"Common Terminology Criteria for Adverse Events (VCOG-CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v1.0","volume":"2","year":"2004","journal-title":"Vet Comp Oncol"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576914002355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576914002355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:06:48Z","timestamp":1761584808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576914002355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S1567576914002355"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2014.06.021","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Suicide plus immune gene therapy prevents post-surgical local relapse and increases overall survival in an aggressive mouse melanoma setting","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2014.06.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}